Arcutis Biotherapeutics Inc (ARQT): Congress and insider trades
Who in Congress and inside the company traded ARQT, when each filing appeared, and what buying after each one would have earned against the S&P 500.
Key Facts
- Arcutis Biotherapeutics Inc (ARQT) is a listed stock on NASDAQ.
- 2 members of Congress filed 4 buys and 2 sells of ARQT, the latest published 2026-06-09 (9 June 2026).
- Insiders filed 0 open market buys worth $0 and 19 sells worth $3.0M, the latest filed 2026-09-10 (10 September 2026).
- Across 4 scored buys, Congress averaged -10.4% against the S&P 500 (SPY) over the 90 days after disclosure, with 25% of them ahead of the index. That result is too few trades to draw a conclusion.
- Data as of 2026-09-29 (29 September 2026).
Congress trades in ARQT
as of 2026-06-09| Filed | Member | Type | Size | Days to file | 90 day vs S&P |
|---|---|---|---|---|---|
| 9 Jun 2026 | Gil Cisneros (D-CA) | buy | 1K–15K | 10 | -0.9% |
| 8 Apr 2026 | Gil Cisneros (D-CA) | buy | 1K–15K | 35 | +6.1% |
| 13 Jan 2026 | Gil Cisneros (D-CA) | sell | 1K–15K | 32 | n/a |
| 16 Oct 2023 | Josh Gottheimer (D-NJ) | sell | 1K–15K | 30 | n/a |
| 19 May 2023 | Josh Gottheimer (D-NJ) | buy | 1K–15K | 32 | -25.1% |
| 25 Jul 2022 | Josh Gottheimer (D-NJ) | buy | 1K–15K | 37 | -21.7% |
Nothing matches that search.
Insider trades in ARQT
as of 2026-09-10| Filed | Insider | Type | Shares | Price | Value | 90 day vs S&P |
|---|---|---|---|---|---|---|
| 10 Sep 2026 | Matsuda Masaru | sell | 9,989 | $25.03 | $250K | n/a |
| 28 Aug 2026 | Curran Terrie | sell | 38,200 | $25.03 | $956K | n/a |
| 24 Aug 2026 | Curran Terrie | sell | 1,072 | $26.04 | $27.9K | n/a |
| 19 Aug 2026 | Welgus Howard G. | sell | 4,730 | $26.18 | $124K | n/a |
| 13 Aug 2026 | Burnett Patrick | sell | 8,300 | $26.52 | $220K | n/a |
| 13 Aug 2026 | Burnett Patrick | sell | 6,700 | $26.08 | $175K | n/a |
| 5 Aug 2026 | Burnett Patrick | sell | 955 | $26.12 | $24.9K | n/a |
| 5 Aug 2026 | Watanabe Todd | sell | 4,375 | $26.12 | $114K | n/a |
| 5 Aug 2026 | Matsuda Masaru | sell | 1,230 | $26.12 | $32.1K | n/a |
| 17 Jul 2026 | Welgus Howard G. | sell | 4,730 | $26.91 | $127K | n/a |
| 17 Jun 2026 | LIN SUE-JEAN | sell | 4,946 | $24.38 | $121K | n/a |
| 17 Jun 2026 | Welgus Howard G. | sell | 635 | $25.67 | $16.3K | n/a |
| 17 Jun 2026 | Welgus Howard G. | sell | 4,096 | $24.41 | $100.0K | n/a |
| 6 May 2026 | Watanabe Todd | sell | 3,172 | $23.61 | $74.9K | n/a |
| 6 May 2026 | Matsuda Masaru | sell | 8,256 | $23.31 | $192K | n/a |
| 6 May 2026 | Vairavan Latha | sell | 1,341 | $23.61 | $31.7K | n/a |
| 6 May 2026 | Burnett Patrick | sell | 684 | $23.61 | $16.1K | n/a |
| 5 May 2026 | Welgus Howard G. | sell | 7,144 | $22.99 | $164K | n/a |
| 3 Apr 2026 | Welgus Howard G. | sell | 10,000 | $23.88 | $239K | n/a |
Nothing matches that search.
Related pages
Frequently asked questions
Who has bought ARQT?
4 Congress buys by 2 members and 0 insider buys are on file. The tables on this page list every one.
Did buying ARQT after a disclosure beat the market?
Across 4 scored buys, Congress averaged -10.4% against the S&P 500 (SPY) over the 90 days after disclosure, with 25% of them ahead of the index. That result is too few trades to draw a conclusion. A single stock is a small sample.
Sources: Congressional trades: STOCK Act disclosures, collected from CapitolTrades. Insider trades: SEC Form 4 filings, collected from Finviz. Prices: Yahoo Finance daily adjusted closes. Data as of 2026-09-29 (29 September 2026). About these sources.
Not investment advice. Past disclosed trades do not predict future returns. Disclosures are published late, so the trades shown are ones you could only have copied after the fact. Talk to a licensed adviser before you invest.